285
FOYDALANILGAN ADABIYOTLAR
1. Осипова В.Н. «Основы физиологии человека и промышленной
токсикологии». Курс лекций для студентов ВУЗов. Издат. МГИУ.
2006; -54 c.
2. Нестерова Е.Н. Основы токсикологии. Учебное пособие для
студентов. –Брянск: Издательство Брянской государственной
инженерно-технологической академии. 2006; -51с.
3. Карабаева З.Т., Аюбова И.Х. Токсикология. Ўқув қўлланма. ТДТУ.
2014, -75 б.
4. Philip C. Burcham. An Introduction to Toxicology. Springer-Verlag
London; -2014.
5. Кельгинбаева С.В. Токсикология. Курс лекций. ТГТУ. Ташкент:
2000.-26 с.
6. Саноцкий И.В., Н.П. Уланова Н.П. Критерии вредности в гигиене и
токсикологии при оценке опасности химических соединений.
Учебное пособие.-М.:
Медицина, 1995. -96 с.
7. Раевский О.А.. Введение в конструирование биологи-чески
активных веществ. Учебное пособие. -М.: РХТИ, 2004. -58 с..
8. Флюри Ф., Церник Ф. Вредные газы. Учебное пособие. -М.: Л.:
2000. -78 с.
9. Голиков С.Н., Саноцкий И.В.. Общие механизмы токси-ческого
действия. Учебное пособие. -Л.: Медицина. 2001. -67 с.
10. Юртов Е.В., Ю.А. Лейкин Ю.А.. Химическая токсиколо-гия. Курс
лекций. -М.: Химия, 2001. -92 с.
11. Bell P. The devil’s doctor: paracelsus and the world of Renaissance
magic and science. London: William Hinemann; 2006.
12. Orfi la M. A general system of toxicology. (This abridged English
translation of Orfi la’s 2-volume text was published M. Carey & Son
(Philadelphia) in 1817 and is available for download from Google
286
Books), 1812.
13.
Boelsterli UA. Mechanistic toxicology: the molecular basis of how
chemikals disrupt biological targets. 2nd ed. Boka Raton: KRK Press;
2007
.
14. Daly AK, Day KP. Genetik association studies in drug-induced liver
injury. Drug Metab Rev. 2012;44:116–26.
15. Leung L et al. Metabolik aktivation in drug-induked liver injury. Drug
Metab Rev. 2012; 44:18–33.
16. Sporn MB, Liby KT. NRF2 and cancer: the good, the bad and the
importance of context. Nat Rev cancer. 2012;12:564–71.
17. West JD, Marnett LJ. Endogenous reactive intermediates as modulators
of cell signaling and cell death. Chem Res Toxicol. 2006;19:173–94.
18. Ikeda T. Drug-induced idiosyncratic hepatotoxicity: prevention strategy
developed after the troglitazone case. Drug Metab Pharmacocinet.
2011;26:60–70.
19. Fromenty B. Bridging the gap between old and new concepts in drug-
induced liver injury. clin Res Hepatol Gastroenterol. 2013;37:6–9.
20. Mellion M et al. Alcohol-related peripheral neuropathy: nutritional, toxic,
or both? Muscle Nerve. 2011;43:309–16.
21. Decramer M et al. Chronic obstructive pulmonary disease. Lancet.
2012;379:1341–51.
22. Vermeulen R et al. Elevated urinary levels of kidney injury molecule-1
among Chinese factory workers exposed to trichloroethylene.
Carcinogenesis. 2012;33:1538–41.
23. Zhang L et al. Identifi cation of identical transcript changes in liver and
whole blood during acetaminophen toxicity. Front Genet. 2012;3:162.
doi:
10.3389/fgene.2012.00162
. Epub 2012 Sep 4.
24. Bowen SE. Two serious and challenging medical complications
associated with volatile substance misuse: sudden sniffi ng death and
fetal solvent syndrome. Subst Use Misuse. 2011;46 Suppl 1:68–72.
Do'stlaringiz bilan baham: